Forest Hills Lab Appoints Dr. Eddy Zhu as Chief CMC Officer

Portfolio - People | Feb 26, 2025 | EIN

Forest Hills Lab Appoints Dr. Eddy Zhu as Chief CMC Officer

Forest Hills Lab, a global life sciences company specializing in regenerative medicine and medical aesthetics, has appointed Dr. Eddy Zhu as their Chief CMC Officer. Dr. Zhu, who brings extensive expertise in pharmaceutical development and regulatory approvals, previously served as Product Development Lead at Sanofi and held director roles at WuXi AppTec. His educational background includes a Ph.D. in Applied Biological Sciences and a Project Management Professional certification. Forest Hills Lab aims to advance its clinical stage biopharmaceutical platform, which focuses on developing therapies for neurodegenerative diseases. Mstone Partners, an incubator of biotech, healthcare, and AI companies, is the largest shareholder of Forest Hills Lab.

Sectors

  • Life Sciences
  • Biopharmaceuticals

Geography

  • United States – The article mentions Paramus, NJ as the location of Forest Hills Lab.

Industry

  • Life Sciences – The article discusses Forest Hills Lab, a life sciences company focusing on regenerative medicine and medical aesthetics.
  • Biopharmaceuticals – Forest Hills Lab is developing therapies for neurological conditions and is advancing its biopharmaceutical platform.

Financials

    Participants

    NameRoleTypeDescription
    Forest Hills LabTarget CompanyCompanyAn innovative global life sciences company focused on regenerative medicine and medical aesthetics.
    Eddy ZhuChief CMC OfficerPersonNew appointee at Forest Hills Lab with extensive experience in pharmaceutical development and regulatory approvals.
    Mstone PartnersLargest ShareholderCompanyAn incubator of biotech, healthcare, and AI companies, supporting Forest Hills Lab.
    Alex YangChair and Chief Executive OfficerPersonCEO of Forest Hills Lab, commenting on Eddy Zhu's appointment.
    SanofiPrevious EmployerCompanyDr. Eddy Zhu's most recent employer, where he served as Product Development Lead.
    WuXi AppTecPrevious EmployerCompanyCompany where Dr. Zhu served as a director for the Parenteral Drug Development Team.